The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.

Johnson & Johnson has come out fighting after Pfizer announced yesterday that it is ready to launch a biosimilar competitor to its blockbuster Remicade. J&J said it had a “biosimilar ...

SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens, it framed the move as a way ...

A man in his 30s has been found dead inside a house in Swindon following the discovery of an 'unidentified vial of liquid'. Emergency services rushed to a house on Collett Avenue at around 4 ...

Recruiting Top Talent across the Global Diabetes Markets and the Point of Care Industry ...